Position in RDNT
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$60,374
+$5,658 QoQ
Shares Held
979
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#16
of 28 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026HIGHLINE WEALTH PARTNERS LLC holds $348,286 across 16 Diagnostics & Research names. RDNT ranks #2 (17.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OPK |
Opko Health, Inc.
|
116,680 | $175,020 | |
| 2 | RDNT |
RadNet, Inc.
This page
|
979 | $60,374 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
109 | $54,648 | |
| 4 | DHR |
Danaher Corp /De/
|
89 | $16,952 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
40 | $7,728 | |
| 6 | NTRA |
Natera, Inc.
|
23 | $6,243 | |
| 7 | ILMN |
Illumina, Inc.
|
30 | $5,274 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
10 | $5,264 |
All Filings in RDNT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,374 | 979 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $54,716 | 979 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $69,851 | 979 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $74,609 | 979 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $55,714 | 979 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $51,410 | 1,034 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $68,373 | 979 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $67,932 | 979 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $57,682 | 979 | Shares | Sole | 2024-10-28 | |
| 2024-03-31 | $48,660 | 1,000 | Shares | Sole | 2024-10-28 | |
| No filing history on record for this holder in this stock. | ||||||